Expert Details
Cardiovascular Disease, Hypertension, Arrhythmiad, Congestive Heart Failure, Internal Med, Lipids
ID: 724864
California, USA
He is an active expert for consulting, medical legal, and workers comp in all fields of general cardiology. He speaks for seven different drug companies and is currently on two large pharmaceutical national advisory panels for cardiology and diabetic drugs. He routinely advises pharmaceutical DMs, RMs, and VPs of sales.
His three most recent consultancies are as follows:
Novartis: A multicenter, randomized, double blind, parallel design trial to evaluate the blood pressure lowering efficacy comparing moderate versus aggressive treatment regimen of Exforge in patients un controlled on ARB monotherapy. CVAA489AUS02.
2008: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects With History of Atherosclerotic Disease: Secondary Prevention of Atherothrombotic Ischemic Events (TRA2 P – TIMI 50).
2008: A Randomized, Double-Blind, Double-Dummy, Parallel Group, Phase3 Efficacy and Safety Study of CGT-2168 Compared with Clopidogrel to Reduce Upper Gastrointestinal Events Including Bleeding and Symptomatic Ulcer Disease Protocol CG104.
Echo Ultrasound Experience:
1995 – Present Echo Interpretations at California Pacific, Mt. Zion, Ralph K. Davies and St. Mary’s, San Francisco, CA.
1986 – 2000 Ultrascan (Mobile Ultrasound) San Francisco, CA.
1981 – 1983 MEDS, (Mobile Ultrasound and Interpretation) San Francisco, CA.
Workers Comp—State of California AME/QME since 1985-present.
Primary experience was AME prior to 2005 reform act.
Equal evaluation experience between applicants and defense.
MPN Treatment- Liberty Mutual, Health First. Other networks pending.
Asbestosis experience.
Family law experience.
Product/pharmaceutical issues.
Novartis-Diovan:
Protocol CVAL 489US13 (Quality of life trial in hypertension QOLITY Study). (Phase 4).
AstraZeneca:
Efficacy and Safety Study of the Oral Direct Thrombin Inhibitor H 376/95 Compared with Dose-Adjusted Warfarin (Coumadin®) in the Prevention of Stroke and Systemic Embolic Events in Patients with Atrial Fibrillation (SPORTIF V) (Phase 3)
Education
| Year | Degree | Subject | Institution |
|---|---|---|---|
| Year: 1973 | Degree: MD | Subject: Medicine | Institution: UCLA |
| Year: 1969 | Degree: BA | Subject: Economics | Institution: University of California Berkeley |
Work History
| Years | Employer | Title | Department |
|---|---|---|---|
| Years: 1979 to 2008 | Employer: Richard Levy, MD | Title: Physician | Department: |
Responsibilities:Available upon request. |
|||
Career Accomplishments
| Associations / Societies |
|---|
| Fellow, American College of Cardiology, 1991. Physicians Recognition Award AMA, 1983. Physicians Recognition Award, AMA, 1987. Physicians Recognition Award, AMA, 1992. Physicians Recognition Award, AMA, 1998. San Francisco Medical Society, 1979-Present. San Francisco Heart Association, 1979-Present. San Francisco Heart Association Speakers Bureau, 1979-1986. Medical Advisor Stonestown YMCA,(S.F.) 1979-1982. Board of Directors Stonestown YMCA,(S.F.) 1979-1981. Bay Area Heart Research Award, 1972-1973. Mt. Zion Hospital – Director, Cardiac Rehabilitation, 1985 – 1987. Phi Delta Epsilon Medical Fraternity, 1981 – present. Israel Heart to Heart Organization, 1990 – Present. California Medical Association, 1979 – Present. American College of Cardiology, California Chapter, 1995 – Present. California Society of Industrial Medicine 1981 – Present. |
| Licenses / Certifications |
|---|
| MD, FACC |
| Publications and Patents Summary |
|---|
| Co-authored or authored 10 medical papers, one scientific presentation at national conference, etc. |
Additional Experience
| Expert Witness Experience |
|---|
| Multiple experiences in trial exposure for both plaintiff and defense. Multiple requests to provide outside consultation for cases and for chat-case review. Malpractice, asbestosis, medical product liability, divorce . State court, rare federal court cases. Over 1000 evaluations for workers comp as AME, QME for California |
| Training / Seminars |
|---|
| American Association of Clinical Research Professionals--Seattle 2006 |
| Vendor Selection |
|---|
| Multiple seminars given for regional pharmaceutical meetings for sales rep enhanced performance |
| Marketing Experience |
|---|
| Advisor for national pharmaceutical companies for cholesterol and diabetes drugs. Speakers programs for eight pharmaceutical companies. Phase 3 and 4 clinical research for 10 years. Advisor to national contract research organization for clinical research trials. |
| Other Relevant Experience |
|---|
| Twenty years giving focus group insight, internet insight for pharma market research. He works very closely with Lucid Systems, a market research company, using neurometrics to help marketing approaches companies in many arenas besides medicine. |
Fields of Expertise
cardiology, cardiovascular diagnostics, cardiovascular pharmacology, cathartic, clinical pharmacology, drug, internal medicine, medical diagnostic imaging, medical diagnostics, pharmaceutics, pharmacology, acute renal failure, antihypertensive drug, arterial compliance, arterial hypertension, cardiac arrhythmia, cardiac valve disease, clinical diagnostics, clinical medicine, clinical protocol, clinical research, clinical study, clinical toxicology, clinical trial, clinical trial documents generation, congestive heart failure, heart, heart disease, hypertension, hypotension, tricuspid valve prolapse, aortic valve prolapse, arrhythmia, mitral valve prolapse, geriatric cardiology